Mike Matson
Stock Analyst at Needham
(3.37)
# 1,003
Out of 5,123 analysts
545
Total ratings
45.97%
Success rate
3.99%
Average return
Main Sectors:
Stocks Rated by Mike Matson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BSX Boston Scientific | Maintains: Buy | $121 → $97 | $77.47 | +25.21% | 35 | Feb 5, 2026 | |
| AORT Artivion | Reiterates: Buy | $58 | $39.41 | +47.17% | 21 | Feb 2, 2026 | |
| SYK Stryker | Maintains: Buy | $448 → $454 | $358.08 | +26.79% | 11 | Jan 30, 2026 | |
| CNMD CONMED | Reiterates: Hold | n/a | $41.14 | - | 26 | Jan 29, 2026 | |
| TFX Teleflex | Upgrades: Buy | $138 | $105.86 | +30.36% | 10 | Jan 27, 2026 | |
| PEN Penumbra | Downgrades: Hold | n/a | $342.11 | - | 14 | Jan 16, 2026 | |
| NEO NeoGenomics | Reiterates: Buy | $14 | $11.36 | +23.24% | 28 | Jan 12, 2026 | |
| ESTA Establishment Labs Holdings | Reiterates: Buy | $84 | $68.33 | +22.93% | 6 | Jan 12, 2026 | |
| MMSI Merit Medical Systems | Reiterates: Buy | $108 | $81.14 | +33.10% | 32 | Jan 9, 2026 | |
| HAE Haemonetics | Downgrades: Hold | n/a | $61.49 | - | 16 | Dec 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $148 → $166 | $134.84 | +23.11% | 14 | Dec 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $3 | $1.22 | +145.90% | 22 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4.25 → $9 | $7.00 | +28.57% | 2 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $10 | $8.08 | +23.76% | 21 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $41 → $44 | $35.88 | +22.63% | 18 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $42 → $26 | $16.56 | +57.00% | 24 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $74.94 | - | 22 | Oct 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $15.03 | - | 21 | Oct 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $64 | $65.65 | -2.51% | 27 | Sep 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $102.27 | - | 21 | Aug 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $57 → $49 | $22.36 | +119.14% | 16 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $44 → $45 | $36.65 | +22.78% | 35 | Jul 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $12 | $5.65 | +112.39% | 19 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $135.08 | - | 25 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $152.33 | - | 5 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $249.15 | - | 11 | Apr 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $88.60 | - | 26 | Feb 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $269.84 | - | 14 | Jan 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $34 → $42 | $15.44 | +172.02% | 2 | May 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $65 → $75 | $88.35 | -15.11% | 1 | Feb 18, 2021 |
Boston Scientific
Feb 5, 2026
Maintains: Buy
Price Target: $121 → $97
Current: $77.47
Upside: +25.21%
Artivion
Feb 2, 2026
Reiterates: Buy
Price Target: $58
Current: $39.41
Upside: +47.17%
Stryker
Jan 30, 2026
Maintains: Buy
Price Target: $448 → $454
Current: $358.08
Upside: +26.79%
CONMED
Jan 29, 2026
Reiterates: Hold
Price Target: n/a
Current: $41.14
Upside: -
Teleflex
Jan 27, 2026
Upgrades: Buy
Price Target: $138
Current: $105.86
Upside: +30.36%
Penumbra
Jan 16, 2026
Downgrades: Hold
Price Target: n/a
Current: $342.11
Upside: -
NeoGenomics
Jan 12, 2026
Reiterates: Buy
Price Target: $14
Current: $11.36
Upside: +23.24%
Establishment Labs Holdings
Jan 12, 2026
Reiterates: Buy
Price Target: $84
Current: $68.33
Upside: +22.93%
Merit Medical Systems
Jan 9, 2026
Reiterates: Buy
Price Target: $108
Current: $81.14
Upside: +33.10%
Haemonetics
Dec 15, 2025
Downgrades: Hold
Price Target: n/a
Current: $61.49
Upside: -
Dec 8, 2025
Maintains: Buy
Price Target: $148 → $166
Current: $134.84
Upside: +23.11%
Nov 13, 2025
Reiterates: Buy
Price Target: $3
Current: $1.22
Upside: +145.90%
Nov 11, 2025
Maintains: Buy
Price Target: $4.25 → $9
Current: $7.00
Upside: +28.57%
Nov 5, 2025
Maintains: Buy
Price Target: $7 → $10
Current: $8.08
Upside: +23.76%
Nov 5, 2025
Maintains: Buy
Price Target: $41 → $44
Current: $35.88
Upside: +22.63%
Oct 29, 2025
Maintains: Buy
Price Target: $42 → $26
Current: $16.56
Upside: +57.00%
Oct 21, 2025
Reiterates: Hold
Price Target: n/a
Current: $74.94
Upside: -
Oct 10, 2025
Reiterates: Hold
Price Target: n/a
Current: $15.03
Upside: -
Sep 3, 2025
Reiterates: Buy
Price Target: $64
Current: $65.65
Upside: -2.51%
Aug 14, 2025
Reiterates: Hold
Price Target: n/a
Current: $102.27
Upside: -
Aug 7, 2025
Maintains: Buy
Price Target: $57 → $49
Current: $22.36
Upside: +119.14%
Jul 30, 2025
Maintains: Buy
Price Target: $44 → $45
Current: $36.65
Upside: +22.78%
May 22, 2025
Upgrades: Buy
Price Target: $12
Current: $5.65
Upside: +112.39%
Apr 10, 2025
Reiterates: Hold
Price Target: n/a
Current: $135.08
Upside: -
Apr 8, 2025
Reiterates: Hold
Price Target: n/a
Current: $152.33
Upside: -
Apr 7, 2025
Reiterates: Hold
Price Target: n/a
Current: $249.15
Upside: -
Feb 7, 2025
Reiterates: Hold
Price Target: n/a
Current: $88.60
Upside: -
Jan 31, 2025
Reiterates: Hold
Price Target: n/a
Current: $269.84
Upside: -
May 4, 2021
Maintains: Buy
Price Target: $34 → $42
Current: $15.44
Upside: +172.02%
Feb 18, 2021
Maintains: Buy
Price Target: $65 → $75
Current: $88.35
Upside: -15.11%